- Home
- ARVN vs CLFD Comparison
ARVN vs CLFD Comparison
Compare ARVN & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CLFD
- Stock Information
- Founded
- ARVN 2015
- CLFD 1979
- Country
- ARVN United States
- CLFD United States
- Employees
- ARVN N/A
- CLFD N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CLFD Telecommunications Equipment
- Sector
- ARVN Health Care
- CLFD Utilities
- Exchange
- ARVN Nasdaq
- CLFD Nasdaq
- Market Cap
- ARVN 456.2M
- CLFD 426.1M
- IPO Year
- ARVN 2018
- CLFD N/A
- Fundamental
- Price
- ARVN $7.53
- CLFD $39.03
- Analyst Decision
- ARVN Buy
- CLFD Strong Buy
- Analyst Count
- ARVN 21
- CLFD 3
- Target Price
- ARVN $20.53
- CLFD $46.67
- AVG Volume (30 Days)
- ARVN 2.2M
- CLFD 194.5K
- Earning Date
- ARVN 07-29-2025
- CLFD 07-31-2025
- Dividend Yield
- ARVN N/A
- CLFD N/A
- EPS Growth
- ARVN N/A
- CLFD N/A
- EPS
- ARVN N/A
- CLFD N/A
- Revenue
- ARVN $426,900,000.00
- CLFD $178,209,000.00
- Revenue This Year
- ARVN $2.83
- CLFD $10.77
- Revenue Next Year
- ARVN N/A
- CLFD $14.46
- P/E Ratio
- ARVN N/A
- CLFD N/A
- Revenue Growth
- ARVN 498.74
- CLFD N/A
- 52 Week Low
- ARVN $5.90
- CLFD $23.78
- 52 Week High
- ARVN $34.11
- CLFD $44.83
- Technical
- Relative Strength Index (RSI)
- ARVN 54.38
- CLFD 67.10
- Support Level
- ARVN $6.70
- CLFD $38.40
- Resistance Level
- ARVN $7.60
- CLFD $39.65
- Average True Range (ATR)
- ARVN 0.45
- CLFD 1.17
- MACD
- ARVN 0.15
- CLFD -0.21
- Stochastic Oscillator
- ARVN 95.04
- CLFD 81.27
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.